Display options
Cite
Wang Q, Zhu L, Jiang Y, et al. miR-219-5p suppresses the proliferation and invasion of colorectal cancer cells by targeting calcyphosin. Oncol Lett. 2017;13(3):1319-1324doi: 10.3892/ol.2017.5570.
Wang, Q., Zhu, L., Jiang, Y., Xu, J., Wang, F., & He, Z. (2017). miR-219-5p suppresses the proliferation and invasion of colorectal cancer cells by targeting calcyphosin. Oncology letters, 13(3), 1319-1324. https://doi.org/10.3892/ol.2017.5570
Wang, Quhui, et al. "miR-219-5p suppresses the proliferation and invasion of colorectal cancer cells by targeting calcyphosin." Oncology letters vol. 13,3 (2017): 1319-1324. doi: https://doi.org/10.3892/ol.2017.5570
Wang Q, Zhu L, Jiang Y, Xu J, Wang F, He Z. miR-219-5p suppresses the proliferation and invasion of colorectal cancer cells by targeting calcyphosin. Oncol Lett. 2017 Mar;13(3):1319-1324. doi: 10.3892/ol.2017.5570. Epub 2017 Jan 04. PMID: 28454255; PMCID: PMC5403531.
Copy Download .nbib Format: NLM
Share it on

Oncol Lett. 2017 Mar;13(3):1319-1324. doi: 10.3892/ol.2017.5570. Epub 2017 Jan 04.

miR-219-5p suppresses the proliferation and invasion of colorectal cancer cells by targeting calcyphosin.

Oncology letters

Quhui Wang, Lirong Zhu, Yasu Jiang, Junfei Xu, Feiran Wang, Zhixian He

Affiliations

  1. Department of General Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China.

PMID: 28454255 PMCID: PMC5403531 DOI: 10.3892/ol.2017.5570

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs involved in an array of biological processes, and their dysregulation is associated with tumor development and progression. One such miRNA, miR-219-5p, is abnormally expressed in patients with colorectal cancer (CRC). In the present study, reverse transcription-quantitative polymerase chain reaction was performed to measure miR-219-5p expression in cells from both CRC tumors, and surrounding healthy tissue. MTT and invasion assays were used to determine the role of miR-219-5p in regulating CRC cell proliferation and invasion, respectively. A luciferase assay was then performed to assess the binding of miR-219-5p to the CAPS gene that encodes calcyphosin protein. The present study confirmed that miR-219-5p expression is significantly downregulated in CRC tissue. miR-219-5p knockdown promoted the growth of HCT-8 cells and increased the expression of calcyphosin protein (CAPS). On the other hand, overexpressing miR-219-5p inhibited HCT-8 cell growth and invasion, and downregulated CAPS expression. In addition, CAPS was identified as the functional downstream target of miR-219-5p by directly targeting its 3'-untranslated region. Therefore, miR-219-5p may function as a tumor suppressor by decreasing CAPS expression, and subsequently inhibit tumor proliferation and invasion. These results indicate that novel therapeutic strategies that increase miR-219-5p expression may be developed to treat CRC.

Keywords: CAPS; colorectal cancer; miR-219-5p; tumor suppression

References

  1. Oncol Lett. 2014 Aug;8(2):711-713 - PubMed
  2. Biochem Biophys Res Commun. 1997 Mar 17;232(2):407-13 - PubMed
  3. EMBO J. 1989 Jan;8(1):111-6 - PubMed
  4. Methods. 2001 Dec;25(4):402-8 - PubMed
  5. J Clin Oncol. 2009 Dec 1;27(34):5848-56 - PubMed
  6. Eur J Biochem. 1979 Dec;102(1):147-52 - PubMed
  7. Am J Pathol. 2010 Oct;177(4):1592-9 - PubMed
  8. J Neuropathol Exp Neurol. 2007 Jun;66(6):505-16 - PubMed
  9. Ann N Y Acad Sci. 1980;356:14-9 - PubMed
  10. Eur J Cancer. 2006 Nov;42(16):2846-54 - PubMed
  11. FEBS Lett. 2012 Mar 23;586(6):884-91 - PubMed
  12. J Proteomics. 2013 Aug 26;89:227-37 - PubMed
  13. Nat Rev Cancer. 2006 Apr;6(4):259-69 - PubMed
  14. J Clin Endocrinol Metab. 2015 Feb;100(2):E204-13 - PubMed
  15. Mol Med. 2013 Feb 08;18:1491-8 - PubMed
  16. Cell. 2004 Jan 23;116(2):281-97 - PubMed
  17. CA Cancer J Clin. 2013 Jan;63(1):11-30 - PubMed
  18. ScientificWorldJournal. 2014 Feb 02;2014:896206 - PubMed
  19. Oncol Rep. 2015 Oct;34(4):1923-32 - PubMed
  20. Nat Rev Cancer. 2009 Apr;9(4):293-302 - PubMed
  21. Gut. 2012 Oct;61(10):1447-53 - PubMed
  22. Tumour Biol. 2015 Nov;36(11):8943-51 - PubMed
  23. J Cell Biol. 1993 Nov;123(4):963-76 - PubMed
  24. Int J Gynecol Cancer. 2010 Jan;20(1):9-15 - PubMed
  25. J Mol Biol. 2008 Nov 14;383(3):455-64 - PubMed
  26. Annu Rev Med. 2009;60:167-79 - PubMed

Publication Types